Fresenius Kabi
Louise Chouard is an accomplished finance professional currently serving as the Finance Controller Europe at Fresenius Kabi since September 2022, where expertise in strategic planning, budgeting, and performance analysis is employed to lead financial strategy and performance across Europe. Prior roles at Fresenius Kabi included International Market Intelligence Analyst, where responsibilities encompassed sales analysis, collaboration with regional marketing and controlling teams, and coordination across multiple countries. Previous experience includes senior and junior auditor roles at PwC France, as well as various positions in accounting and finance, including an Assistant Accountant at FOX AUDIT and a mission officer at LEADER PRICE. Louise holds a Master’s degree in Audit from ESSCA and has a strong background in financial analysis, risk management, and stakeholder collaboration.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
16 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.